471 related articles for article (PubMed ID: 27101975)
1. Glucitol-core containing gallotannins inhibit the formation of advanced glycation end-products mediated by their antioxidant potential.
Ma H; Liu W; Frost L; Kirschenbaum LJ; Dain JA; Seeram NP
Food Funct; 2016 May; 7(5):2213-22. PubMed ID: 27101975
[TBL] [Abstract][Full Text] [Related]
2. Cosmetic applications of glucitol-core containing gallotannins from a proprietary phenolic-enriched red maple (Acer rubrum) leaves extract: inhibition of melanogenesis via down-regulation of tyrosinase and melanogenic gene expression in B16F10 melanoma cells.
Ma H; Xu J; DaSilva NA; Wang L; Wei Z; Guo L; Johnson SL; Lu W; Xu J; Gu Q; Seeram NP
Arch Dermatol Res; 2017 May; 309(4):265-274. PubMed ID: 28283753
[TBL] [Abstract][Full Text] [Related]
3. Bioactive Glucitol-Core Containing Gallotannins and other Phytochemicals from Silver Maple (Acer saccharinum) Leaves.
Muhsinah AB; Ma H; Dasilva NA; Yuan T; Seeram NP
Nat Prod Commun; 2017 Jan; 12(1):83-84. PubMed ID: 30549831
[TBL] [Abstract][Full Text] [Related]
4. Pycnalin, a new α-glucosidase inhibitor from Acer pycnanthum.
Ogawa A; Miyamae Y; Honma A; Koyama T; Yazawa K; Shigemori H
Chem Pharm Bull (Tokyo); 2011; 59(5):672-5. PubMed ID: 21532209
[TBL] [Abstract][Full Text] [Related]
5. Maplexins, new α-glucosidase inhibitors from red maple (Acer rubrum) stems.
Wan C; Yuan T; Li L; Kandhi V; Cech NB; Xie M; Seeram NP
Bioorg Med Chem Lett; 2012 Jan; 22(1):597-600. PubMed ID: 22079755
[TBL] [Abstract][Full Text] [Related]
6. Anti-glycation and anti-oxidative effects of a phenolic-enriched maple syrup extract and its protective effects on normal human colon cells.
Liu W; Wei Z; Ma H; Cai A; Liu Y; Sun J; DaSilva NA; Johnson SL; Kirschenbaum LJ; Cho BP; Dain JA; Rowley DC; Shaikh ZA; Seeram NP
Food Funct; 2017 Feb; 8(2):757-766. PubMed ID: 28112327
[TBL] [Abstract][Full Text] [Related]
7. Structure Activity Related, Mechanistic, and Modeling Studies of Gallotannins containing a Glucitol-Core and
Ma H; Wang L; Niesen DB; Cai A; Cho BP; Tan W; Gu Q; Xu J; Seeram NP
RSC Adv; 2015 Jan; 5(130):107904-107915. PubMed ID: 26989482
[TBL] [Abstract][Full Text] [Related]
8. Phenolics from Eugenia jambolana seeds with advanced glycation endproduct formation and alpha-glucosidase inhibitory activities.
Liu F; Ma H; Wang G; Liu W; Seeram NP; Mu Y; Xu Y; Huang X; Li L
Food Funct; 2018 Aug; 9(8):4246-4254. PubMed ID: 30009284
[TBL] [Abstract][Full Text] [Related]
9. New Gallotannin and other Phytochemicals from Sycamore Maple (Acer pseudoplatanus) Leaves.
Zhang L; Tu ZC; Yuan T; Ma H; Niesen DB; Wang H; Seeram NP
Nat Prod Commun; 2015 Nov; 10(11):1977-80. PubMed ID: 26749841
[TBL] [Abstract][Full Text] [Related]
10. Annona muricata Linn. leaf as a source of antioxidant compounds with in vitro antidiabetic and inhibitory potential against α-amylase, α-glucosidase, lipase, non-enzymatic glycation and lipid peroxidation.
Justino AB; Miranda NC; Franco RR; Martins MM; Silva NMD; Espindola FS
Biomed Pharmacother; 2018 Apr; 100():83-92. PubMed ID: 29425747
[TBL] [Abstract][Full Text] [Related]
11. The hydrolyzable gallotannin, penta-O-galloyl-β-D-glucopyranoside, inhibits the formation of advanced glycation endproducts by protecting protein structure.
Ma H; Liu W; Frost L; Wang L; Kong L; Dain JA; Seeram NP
Mol Biosyst; 2015 May; 11(5):1338-47. PubMed ID: 25789915
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Comparative Structure-Activity Study of Carbohydrate-Based Phenolic Compounds as α-Glucosidase Inhibitors and Antioxidants.
Machida S; Mukai S; Kono R; Funato M; Saito H; Uchiyama T
Molecules; 2019 Nov; 24(23):. PubMed ID: 31783621
[TBL] [Abstract][Full Text] [Related]
13. Anti-hyperglycaemic effects of the Japanese red maple Acer pycnanthum and its constituents the ginnalins B and C.
Honma A; Koyama T; Yazawa K
J Enzyme Inhib Med Chem; 2011 Apr; 26(2):176-80. PubMed ID: 20560858
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Advanced Glycation End Products, Sorbitol, and Aldose Reductase by Hydroalcohol Extract of Lagenaria siceraria Mol Standl in Diabetic Complications: An In Vitro Approach.
Kajal A; Singh R
J Diet Suppl; 2018 Jul; 15(4):482-498. PubMed ID: 28956665
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory action on the production of advanced glycation end products (AGEs) and suppression of free radicals in vitro by a Sri Lankan polyherbal formulation Nawarathne Kalka.
Fernando CD; Karunaratne DT; Gunasinghe SD; Cooray MC; Kanchana P; Udawatte C; Perera PK
BMC Complement Altern Med; 2016 Jul; 16():197. PubMed ID: 27391698
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Evaluation of Gallotannin Derivatives as Antioxidants and α-Glucosidase Inhibitors.
Machida S; Sugaya M; Saito H; Uchiyama T
Chem Pharm Bull (Tokyo); 2021; 69(12):1209-1212. PubMed ID: 34853289
[TBL] [Abstract][Full Text] [Related]
17. Antidiabetic effects of Syzygium cumini leaves: A non-hemolytic plant with potential against process of oxidation, glycation, inflammation and digestive enzymes catalysis.
Franco RR; Ribeiro Zabisky LF; Pires de Lima Júnior J; Mota Alves VH; Justino AB; Saraiva AL; Goulart LR; Espindola FS
J Ethnopharmacol; 2020 Oct; 261():113132. PubMed ID: 32673709
[TBL] [Abstract][Full Text] [Related]
18. Development of an antidiabetic polyherbal formulation (ADPHF6) and assessment of its antioxidant activity against ROS-induced damage in pUC19 and human lymphocytes - an in vitro study.
Shanmugasundaram D; Duraiswamy A; Viswanathan A; Sasikumar CS; Cherian SM; Cherian KM
J Complement Integr Med; 2016 Sep; 13(3):267-274. PubMed ID: 27352446
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory Effects of Siegesbeckia orientalis Extracts on Advanced Glycation End Product Formation and Key Enzymes Related to Metabolic Syndrome.
Hung WC; Ling XH; Chang CC; Hsu HF; Wang SW; Lee YC; Luo C; Lee YT; Houng JY
Molecules; 2017 Oct; 22(10):. PubMed ID: 29065451
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of Clitoria ternatea flower petal extract on fructose-induced protein glycation and oxidation-dependent damages to albumin in vitro.
Chayaratanasin P; Barbieri MA; Suanpairintr N; Adisakwattana S
BMC Complement Altern Med; 2015 Feb; 15():27. PubMed ID: 25887591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
